Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @TIDESInforma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TIDESInforma
-
Prikvačeni tweet
We surveyed 162
#TIDES professionals about the state of the industry for 2018. These were the results... https://knect365.com/next-generation-therapeutics/article/87366c05-773e-462a-8bc7-c6c444a82539/tides-state-of-the-industry-survey-report-2018?utm_source=twitter&utm_medium=social&utm_campaign=TIDES%202018%20survey%20report …#oligonucleotide#peptidepic.twitter.com/M5Cby1SVZf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can you avoid new therapies being derailed by regulatory processes? This whitepaper presents successful strategies for peptide, oligonucleotide and mRNA therapeutic products. http://spr.ly/60141gmTm pic.twitter.com/uyU1UON5JR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Edie Stringfellow
@MassBio identifies six#DiversityandInclusion best practices that biotech and pharma companies can use to directly improve their workplace culture.#BiotechWeekBoston http://spr.ly/6010158nC pic.twitter.com/Gmmf45FV1y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can you navigate the regulatory maze to get peptide, oligonucleotide and mRNA therapies to market? This whitepaper presents successful strategies & case studies. http://spr.ly/6017158nf pic.twitter.com/q16wl5660d
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Knud Jensen, Professor, Department of Chemistry at
@uni_copenhagen, discusses how can academia and biotechs can work better together to both benefithttps://www.youtube.com/watch?v=3qZZxJ37FgU …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Macarena Hernández Jiménez, CSO at AptaTargets, discusses how the
#biotech company is using therapeutic aptamers to treat#Stroke, as well as the main challenges that need to be overcomehttps://www.youtube.com/watch?v=sTmw2dwm-VU …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What’s the recipe for getting peptide, oligonucleotide and mRNA treatments approved? This whitepaper explores how to navigate the current regulatory frameworks.http://spr.ly/6016158Vm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are leading biotech and pharma organizations successfully implementing
#DiversityandInclusion initiatives? Here are 6 best practices chosen by Edie Stringfellow@MassBio#BiotechWeekBoston http://spr.ly/6010158V0 pic.twitter.com/3TcUDMrh74
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can you avoid new therapies being derailed by regulatory processes? This whitepaper presents successful strategies for peptide, oligonucleotide and mRNA therapeutic products. http://spr.ly/6016158uA pic.twitter.com/f6A8oh10oo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
John Lopez, Process Development Chemist at
@Novartis, explores how#AI can revolutionize chemistry to make it a#data driven fieldhttps://www.youtube.com/watch?v=KWQ4P4NlEYk …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can you navigate the regulatory maze to get peptide, oligonucleotide and mRNA therapies to market? This whitepaper presents successful strategies & case studies. http://spr.ly/60151elXB pic.twitter.com/a0NTfYSkLY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Edie Stringfellow
@MassBio identifies six#DiversityandInclusion best practices that biotech and pharma companies can use to directly improve their workplace culture.#BiotechWeekBoston http://spr.ly/6018158up pic.twitter.com/dRKt6MGm9a
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Knud Jensen, Professor, Department of Chemistry at
@uni_copenhagen, discusses how can academia and biotechs can work better together to both benefithttps://www.youtube.com/watch?v=3qZZxJ37FgU …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are leading biotech and pharma organizations successfully implementing
#DiversityandInclusion initiatives? Here are 6 best practices chosen by Edie Stringfellow@MassBio#BiotechWeekBoston http://spr.ly/60161elR2 pic.twitter.com/AivLJAoSY3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What’s the recipe for getting peptide, oligonucleotide and mRNA treatments approved? This whitepaper explores how to navigate the current regulatory frameworks.http://spr.ly/60181elum
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Christine Dieterich, Senior Project Manager CMC & Preclinical at
@IndexPharm, explores how the company is working with single strain#DNA#oligonucleotides focused on inflammatory diseaseshttps://www.youtube.com/watch?v=r0ypaIi85xE …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
John Lopez, Process Development Chemist at
@Novartis, explores how#AI can revolutionize chemistry to make it a#data driven fieldhttps://www.youtube.com/watch?v=KWQ4P4NlEYk …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Edie Stringfellow
@MassBio identifies six#DiversityandInclusion best practices that biotech and pharma companies can use to directly improve their workplace culture.#BiotechWeekBoston http://spr.ly/60121diZ2 pic.twitter.com/nPRbigG3X5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Knud Jensen, Professor, Department of Chemistry at
@uni_copenhagen, discusses how can academia and biotechs can work better together to both benefithttps://www.youtube.com/watch?v=3qZZxJ37FgU …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are leading biotech and pharma organizations successfully implementing
#DiversityandInclusion initiatives? Here are 6 best practices chosen by Edie Stringfellow@MassBio#BiotechWeekBoston http://spr.ly/60181dikq pic.twitter.com/Sz1mNIVO5i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Macarena Hernández Jiménez, CSO at AptaTargets, discusses how the
#biotech company is using therapeutic aptamers to treat#Stroke, as well as the main challenges that need to be overcomehttps://www.youtube.com/watch?v=sTmw2dwm-VU …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.